Loading organizations...
§ Private Profile · Moscow, Moscow City, Russian Federation
Management consultancy providing data science analytics services to healthcare & life science organizations for system efficiency.
Akeso is a London, UK-based management consultancy that provides advanced data analytics and strategic advisory services to healthcare, social care, and life science organizations. The firm utilizes sophisticated data science techniques, including predictive analytics, natural language processing, and patient pathway simulation, to optimize clinical decision support and overall operational efficiency. Operating primarily through a business-to-business model, the company aims to deliver £350 million in measurable financial and operational benefits to the regional healthcare system by the year 2025. Akeso serves a diverse portfolio of public and private sector clients, notably supporting the broader UK healthcare system, national COVID-19 vaccine rollout programs, and various prominent life sciences enterprises across the region. The organization was originally established in Cambridge before relocating its corporate headquarters, and it was formally founded in 2013 by co-founders Chris Robson and Scott Healy.
Akeso has raised $150.0M across 1 funding round.
Akeso has raised $150.0M in total across 1 funding round.
Akeso has raised $150.0M in total across 1 funding round.
Akeso's investors include Loyal Valley Capital, Sino Biopharmaceutical, AIHC Capital, CDG International, Lake Bleu Capital, OrbiMed, Shenzhen Capital Group.
Akeso has raised $150.0M across 1 funding round. Most recently, it raised $150.0M Series D in November 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 9, 2019 | $150M Series D | Loyal Valley Capital, Sino Biopharmaceutical | Aihc Capital, CDG International, Lake Bleu Capital, OrbiMed, Shenzhen Capital Group | Announced |